mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Malignant Transformation of Branch Duct–Type Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on Contrast-Enhanced Endoscopic Ultrasonography Morphological Changes: Focus on Malignant Transformation of Intraductal Papillary Mucinous Neoplasm Itself

Ohno E et al. – Malignant transformation of branch duct–type intraductal papillary mucinous neoplasm (BD–IPMN) is not rare. The observation of morphological changes of main pancreatic duct and nodules, mainly on contrast–enhanced endoscopic ultrasonography, is practical and useful for predicting malignant transformation (MT) of BD–IPMN itself.

Methods
  • The subjects consisted of 142 patients who underwent contrast-enhanced endoscopic ultrasonography for initial diagnosis from January 2001 with more than 12 months of follow-up.
  • The MT rate, including the co-occurrence of invasive ductal cancer, was evaluated by univariate and multivariate analysis.
  • In addition, on the basis of morphological changes in patients who underwent surgery, the predictive factors for malignant IPMNs were evaluated.

Results
  • Median follow-up term was 42.5 months (range, 12-105 months).
  • Thirty patients who exhibited morphological changes underwent surgery.
  • Malignant transformation occurred in 9 patients (6.3%), and 5-year MT rate was 10.7%.
  • The co-occurrence of invasive ductal cancer was seen in 5 patients.
  • Multivariate analysis showed that the existence of mural nodules at initial diagnosis and involvement of main pancreatic duct were significant predictors of MT of BD-IPMN.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close